Renal function in patients receiving tenofovir with ritonavir/lopinavir or ritonavir/atazanavir in the HIV Outpatient Study (HOPS) cohort

J Acquir Immune Defic Syndr. 2006 Dec 15;43(5):626-8. doi: 10.1097/01.qai.0000242461.35768.45.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenine / adverse effects
  • Adenine / analogs & derivatives*
  • Adenine / therapeutic use
  • Adult
  • Atazanavir Sulfate
  • Cohort Studies
  • Female
  • HIV Infections / drug therapy*
  • Humans
  • Kidney / drug effects*
  • Lopinavir
  • Male
  • Oligopeptides / adverse effects*
  • Oligopeptides / therapeutic use
  • Organophosphonates / adverse effects*
  • Organophosphonates / therapeutic use
  • Pyridines / adverse effects*
  • Pyridines / therapeutic use
  • Pyrimidinones / adverse effects*
  • Pyrimidinones / therapeutic use
  • Ritonavir / adverse effects*
  • Ritonavir / therapeutic use
  • Tenofovir

Substances

  • Oligopeptides
  • Organophosphonates
  • Pyridines
  • Pyrimidinones
  • Lopinavir
  • Atazanavir Sulfate
  • Tenofovir
  • Adenine
  • Ritonavir